¿Hasta dónde se puede bajar la presión arterial?

Do we need more long-term outcome trials for the treatment of hypertension?

The journal of the Royal College of Physicians of Edinburgh·2011

Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension.

Journal of human hypertension·2009

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2007

Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study.

European journal of neurology·2005

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Journal of human hypertension·2005

Why not prescribe the best drugs for hypertension now?

Journal of human hypertension·2003

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction.

Case reports in critical care·2026

Percutaneous Thrombectomy for Clot-in-Transit With Concomitant Left Ventricular Thrombus in a Patient With Acute Heart Failure Exacerbation: A Case Report.

Cureus·2026

Recurrent Acute Limb Ischemia and Direct Oral Anticoagulant Failure: A Case of Suspected Antiphospholipid Syndrome Triggered by Mechanical Compression.

Cureus·2026

Unusual Coexistence of Takayasu Arteritis, Diffuse Coronary Aneurysms, and a Large Left Atrial Myxoma in an Elderly Male: A Case Report and Literature Review.

Cureus·2026

Remimazolam-based anesthesia in sepsis patients: a retrospective cohort study of hemodynamic stability and postoperative outcomes.

Frontiers in medicine·2026

Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.

Frontiers in neurology·2026

Videos de Experimentos Relacionados

¿Hasta dónde se puede bajar la presión arterial?

Videos de Conceptos Relacionados

Do we need more long-term outcome trials for the treatment of hypertension?

Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension.

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study.

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Why not prescribe the best drugs for hypertension now?

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction.

Percutaneous Thrombectomy for Clot-in-Transit With Concomitant Left Ventricular Thrombus in a Patient With Acute Heart Failure Exacerbation: A Case Report.

Recurrent Acute Limb Ischemia and Direct Oral Anticoagulant Failure: A Case of Suspected Antiphospholipid Syndrome Triggered by Mechanical Compression.

Unusual Coexistence of Takayasu Arteritis, Diffuse Coronary Aneurysms, and a Large Left Atrial Myxoma in an Elderly Male: A Case Report and Literature Review.

Remimazolam-based anesthesia in sepsis patients: a retrospective cohort study of hemodynamic stability and postoperative outcomes.

Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.

Videos de Experimentos Relacionados

¿Hasta dónde se puede bajar la presión arterial?

Videos de Conceptos Relacionados

Artículos Relacionados